pacific neuroscience logo
pacific neuroscience medical group

research
introduction
areas of expertise
experience
parametrics
subinvestigators
drug companies
CRO's
central labs
review boards
current studies
how to volunteer

current studies > Alzheimer's (mild - moderate)
Clinical trials for patients with mild to moderate Alzheimer's disease test experimental medications that may improve cognitive function without affecting disease progression, or interventions that may slow the degenerative process that causes memory loss and other symptoms. Patients are usually able to continue taking medications prescribed for the treatment of Alzheimer's disease, as long as the doses remain stable during the study period. Our studies for patients with mild to moderate Alzheimer's disease are listed below:


Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease (ACCTION) enrollment is closed for this study


Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid ß Antibody in Patients with Alzheimer’s Disease enrollment is closed for this study


how to volunteer >>

CURRENT STUDIES
Alzheimer's disease
early
mild to moderate
Parkinson's disease
early
advanced
FEATURED EVENTS
free memory screenings
educational events